Health Payer Intelligence September 12, 2023
In addition to lower out-of-pocket costs, Medicare Advantage beneficiaries with cancer have better access to care management and palliative care than those in fee-for-service.
Medicare Advantage beneficiaries with cancer experienced lower out-of-pocket costs and had access to more benefits than those in Medicare fee-for-service (FFS), research conducted by ATI Advisory and commissioned by the Better Medicare Alliance found.
Over 20 million Medicare beneficiaries are cancer patients or survivors, 37 percent of whom were enrolled in Medicare Advantage as of 2019.
ATI Advisory researchers used the 2019 Medicare Current Beneficiary Survey and Cost Supplement file and Medicare Part A and Part B claims for FFS beneficiaries to compare Medicare Advantage and FFS beneficiaries with cancer on demographics, cost protections, and healthcare...